Template:Ceftaroline: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
Line 24: Line 24:
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Ceftaroline how supplied|How Supplied]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Ceftaroline how supplied|How Supplied]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Ceftaroline compatibility and stability |Compatibility and Stability ]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Ceftaroline clinical studies|Clinical Studies ]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Ceftaroline direction for use|Direction For Use]]
 
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Ceftaroline labels and packages|Labels and Packages]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Ceftaroline labels and packages|Labels and Packages]]
|-
|-
|}
|}

Latest revision as of 08:28, 6 January 2014